172 related articles for article (PubMed ID: 37491976)
1. Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy.
Kanji S; Roger C; Taccone FS; Muller L
Pharmacotherapy; 2023 Nov; 43(11):1194-1205. PubMed ID: 37491976
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring of Antibiotic Drugs in Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis: A Critical Review.
Matusik E; Boidin C; Friggeri A; Richard JC; Bitker L; Roberts JA; Goutelle S
Ther Drug Monit; 2022 Feb; 44(1):86-102. PubMed ID: 34772891
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
Hoff BM; Maker JH; Dager WE; Heintz BH
Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
[No Abstract] [Full Text] [Related]
4. Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software.
Roberts JA; Bellomo R; Cotta MO; Koch BCP; Lyster H; Ostermann M; Roger C; Shekar K; Watt K; Abdul-Aziz MH
Intensive Care Med; 2022 Oct; 48(10):1338-1351. PubMed ID: 35997793
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermittent renal replacement therapy: A systematic review.
Grewal A; Thabet P; Dubinsky S; Purkayastha D; Wong K; Marko R; Hiremath S; Hutton B; Kanji S
Pharmacotherapy; 2023 Nov; 43(11):1206-1220. PubMed ID: 37596844
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
[TBL] [Abstract][Full Text] [Related]
7. Drug dosing considerations in continuous renal replacement therapy.
Jang SM; Awdishu L
Semin Dial; 2021 Nov; 34(6):480-488. PubMed ID: 33939855
[TBL] [Abstract][Full Text] [Related]
8. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
[TBL] [Abstract][Full Text] [Related]
9. SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.
Roberts JA; Choi GY; Joynt GM; Paul SK; Deans R; Peake S; Cole L; Stephens D; Bellomo R; Turnidge J; Wallis SC; Roberts MS; Roberts DM; Lassig-Smith M; Starr T; Lipman J
BMC Infect Dis; 2016 Mar; 16():103. PubMed ID: 26932762
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
Heintz BH; Matzke GR; Dager WE
Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: Sustained low-efficiency dialysis and continuous veno-venous haemodialysis.
Westermann I; Gastine S; Müller C; Rudolph W; Peters F; Bloos F; Pletz M; Hagel S
Br J Clin Pharmacol; 2021 Nov; 87(11):4293-4303. PubMed ID: 33818823
[TBL] [Abstract][Full Text] [Related]
12. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
[TBL] [Abstract][Full Text] [Related]
13. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic therapy in sepsis: No next time for a second chance!
Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
[TBL] [Abstract][Full Text] [Related]
15. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy.
Kuang D; Verbine A; Ronco C
Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
Pea F; Viale P; Pavan F; Furlanut M
Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
[TBL] [Abstract][Full Text] [Related]
19. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.
Dubinsky S; Watt K; Saleeb S; Ahmed B; Carter C; Yeung CHT; Edginton A
Clin Pharmacokinet; 2022 Feb; 61(2):189-229. PubMed ID: 34846703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
